These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 1674882)
1. Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia. Deutch AY; Moghaddam B; Innis RB; Krystal JH; Aghajanian GK; Bunney BS; Charney DS Schizophr Res; 1991; 4(2):121-56. PubMed ID: 1674882 [TBL] [Abstract][Full Text] [Related]
2. Atypical antipsychotics: mechanism of action. Seeman P Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706 [TBL] [Abstract][Full Text] [Related]
3. Towards more effective antipsychotic treatment. Kane JM; Freeman HL Br J Psychiatry Suppl; 1994 Nov; (25):22-31. PubMed ID: 7865194 [TBL] [Abstract][Full Text] [Related]
4. The importance of serotonin-dopamine interactions in the action of clozapine. Meltzer HY Br J Psychiatry Suppl; 1992 May; (17):22-9. PubMed ID: 1358125 [TBL] [Abstract][Full Text] [Related]
5. Serotonin receptors: their key role in drugs to treat schizophrenia. Meltzer HY; Li Z; Kaneda Y; Ichikawa J Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974 [TBL] [Abstract][Full Text] [Related]
6. Review the role of dopamine D4 receptors in schizophrenia and antipsychotic action. Sanyal S; Van Tol HH J Psychiatr Res; 1997; 31(2):219-32. PubMed ID: 9278187 [TBL] [Abstract][Full Text] [Related]
7. The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research. Kerwin RW Br J Psychiatry; 1994 Feb; 164(2):141-8. PubMed ID: 7513599 [No Abstract] [Full Text] [Related]
8. Conventional versus novel antipsychotics: changing concepts and clinical implications. Remington G; Chong SA J Psychiatry Neurosci; 1999 Nov; 24(5):431-41. PubMed ID: 10586534 [TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy of schizophrenia: a review. Sigmundson HK Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S70-5. PubMed ID: 7533053 [TBL] [Abstract][Full Text] [Related]
10. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis. Kuroki T; Nagao N; Nakahara T Prog Brain Res; 2008; 172():199-212. PubMed ID: 18772034 [TBL] [Abstract][Full Text] [Related]
17. Antipsychotic drug mechanisms and neurotransmitter systems in schizophrenia. Reynolds GP Acta Psychiatr Scand Suppl; 1994; 380():36-40. PubMed ID: 7914046 [TBL] [Abstract][Full Text] [Related]
18. The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs. Meltzer HY; Matsubara S; Lee JC Psychopharmacol Bull; 1989; 25(3):390-2. PubMed ID: 2576319 [TBL] [Abstract][Full Text] [Related]
19. "Hit-and-run" actions at dopamine receptors, part 1: Mechanism of action of atypical antipsychotics. Stahl SM J Clin Psychiatry; 2001 Sep; 62(9):670-1. PubMed ID: 11681760 [TBL] [Abstract][Full Text] [Related]
20. New insights into the biology of schizophrenia through the mechanism of action of clozapine. Brunello N; Masotto C; Steardo L; Markstein R; Racagni G Neuropsychopharmacology; 1995 Nov; 13(3):177-213. PubMed ID: 8602893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]